Connect with us

Business

SōRSE Technology Corp Gives Vext Science Inc. (OTCMKTS: VEXTF) Exclusive Rights to Sell its MAJOR Cannabis-Infused Beverages in Arizona

Published

on

Just like many other institutions across the globe, the pandemics and public health emergencies, including those related to COVID-19, impacted heavily on Vext Science Inc. (OTCMKTS: VEXTF)  Manufacturing, supply chain, project development, and shipping are some of the areas, which faced severe disruptions, including shutdowns. Nonetheless, even with these challenges, and the underlying uncertainty of how long the pandemic persists, the company still seeks to grow its network. 

The cannabinoid brand leader based in Arizona has inked a Memorandum of Understanding with SōRSE Technology Corp. Given its expertise in extraction, manufacturing, cultivation, and marketing, VEXTF will exclusively produce and sell SōRSE’s MAJOR cannabis-infused beverages in Arizona. 

The MOU outlines that SōRSE provides all know-how and formulations for creating MAJOR 100mg THC cannabis-infused beverages. Meanwhile, upon the signing of a final agreement, Vext will part with an initial royalty of US$100,000, a fixed price for SōRSE emulsion, and later on a fixed price per unit produced. 

Beverages are a Key Growth Segment for Vext

MAJOR is supposedly a high-dose THC beverage known to deliver a consistent and enjoyable cannabis experience. It does not have any cannabis taste or smell and is available in Orange Mango, Pink Lemonade, Blue Raspberry, Passion Fruit, and Grape flavors. Recent data from Headset revealed that it was the top-selling cannabis beverage brand in the U.S. during Q1 20211. 

This explains the reason why Vext considers beverages a primary area of revenue growth. “…we are excited to announce this deal to bring MAJOR beverages – produced and sold by Vapen – to consumers in Arizona… and will round-out Vapen’s offering of concentrates, extracts, edibles, vapes, topicals and tinctures,” Eric Offenberger, CEO of Vext announced. 

Approval to Build and Operate a State-Of-The-Art Medical Cannabis Cultivation Operation

Vext Science, Inc. treats product quality and purity as their core marketing strategies. Hence, the closure of the $4.3 million in cash purchase of Eloy Facility, a vacant 72,000 square foot industrial located in Arizona, is worth celebrating. Additional good news is that the facility occupies ample land for future expansion. Still, once it is operational, it will offer 58,000 square feet indoor capacity under a canopy and 10 acres of outdoor capacity. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business36 seconds ago

SōRSE Technology Corp Gives Vext Science Inc. (OTCMKTS: VEXTF) Exclusive Rights to Sell its MAJOR Cannabis-Infused Beverages in Arizona

Post Views: 2 Just like many other institutions across the globe, the pandemics and public health emergencies, including those related...

Business2 mins ago

CONSERVATIVE BROADCAST MEDIA JOURNALISM Ord Shs (OTCMKTS: CBMJ) Records $1.827M in Revenue for the First Six Months of 2021 Achieving Its First-Ever Quarterly Sales Exceeding $1.0M

Post Views: 3 The most valuable asset an industry could offer is information and knowledge. CONSERVATIVE BROADCAST MEDIA JOURNALISM Ord...

Business4 mins ago

Livewire Ergogenics Inc. (OTCMKTS: LVVV) Receives Authorization to Operate Commercial Cannabis Business from the County of San Luis Obispo, California

Post Views: 3 Cannabinoid products are ubiquitous today in the health and wellness industry. Many companies are consistently pushing in...

Business41 mins ago

The Israeli Ministry of Health and Helsinki Approves a Phase IIa Clinical Trial of SCI-110, a Treatment for Alzheimer’s disease and Agitation, SciSparc Ltd (OTCMKTS: SPRCY) says

Post Views: 14 Alzheimer’s disease (AD) may not be as common as many other neurodegenerative diseases. However, it can be...

Business23 hours ago

Canada House Wellness Group Inc.’s (OTCMKTS: SARSF) Subsidiary Abba Medix Corp Hits 1000 Enrolments

Post Views: 16 Canada House Wellness Group Inc. (OTCMKTS: SARSF) has announced that its subsidiary Abba Medix Corp has hit...

Business24 hours ago

Tilray Inc.’s (NASDAQ: TLRY) Completes First Cannabis Harvest From Its Germany Facility

Post Views: 20 Tilray Inc.’s (NASDAQ: TLRY) Germany subsidiary, Aphria RX GmbH, has concluded the first medical cannabis harvest grown...